Vanguard FTSE Developed Markets ETF

Most Recent

  • People discussing stock options
    Guides

    You Can Own a Piece of the Entire Stock Market—Here’s How

    By Adam Goodpasture
  • uploads///unemployment gap
    Macroeconomic Analysis

    Labor Market Slack Impacts Prices and Wages

    If the unemployment gap is declining and the participation gap is rising, it could be due to an increase in labor market slack.

    By Surbhi Jain
  • uploads///phg pm
    Company & Industry Overviews

    Philips Announced the Pricing of Its Lighting IPO

    Koninklijke Philips (PHG) raised 750 million euros ($839 million) from its initial public offering (or IPO) of its Lighting business.

    By Gabriel Kane
  • uploads///CTAs performed when equities slumped
    Miscellaneous

    Why Commodity Trading Advisors Fare Well When Nothing Else Works

    CTAs (commodity trading advisors) offer diversification benefits (commodity exposure when the equity markets are down), along with liquidity.

    By Surbhi Jain
  • uploads///european
    Macroeconomic Analysis

    Markets Extend Rally on Stimulus Hopes, FTSE 100 Remains Flat

    The FTSE 100, the United Kingdom’s major index (EWU), has been on rising trend after the sharp fall for two days following the Brexit referendum.

    By David Meyer
  • uploads///Abenomics
    Company & Industry Overviews

    What Paul Krugman Thinks about Japan’s Yield Curve Control Policy

    In its latest policy move, the Bank of Japan left rates unchanged and delayed inflation target timings for the Japanese economy (EWJ) (HEWJ) (DXJ).

    By Surbhi Jain
  • uploads///latin america price performance
    Company & Industry Overviews

    Investing in Latin America Can Bear Fruit, but Should We?

    With commodity prices recovering and major developed markets (EFA) (VEA) caught in the lull, Latin America should see sunnier days ahead.

    By Surbhi Jain
  • uploads///CP Carloads
    Miscellaneous

    How Canadian Pacific Railway’s Volumes Compared to Peers

    Canadian Pacific Railway (CP) is Canada’s second-largest freight rail.

    By Samuel Prince
  • uploads///CP Carloads
    Miscellaneous

    Canadian Pacific Railway: Rise in Railcars Cover Intermodal Fall in Week 33

    Canadian Pacific Railway witnessed a volume loss in the intermodal space in week 33 of 2017.

    By Samuel Prince
  • Energy & Utilities

    Overview: An introduction to Mars pipelines’ expansion program

    Mars’ mainline capacity is a 54-mile segment from the connections to Ursa and Medusa at the West Delta to the connection with the Amberjack pipeline at Fourchon, Louisiana.

    By Alex Chamberlin
  • uploads///EBITDA
    Energy & Utilities

    Why is Shell expecting to increase revenue and earnings by 2015?

    Revenues from the Bengal refined pipeline operation is expected to decrease by 6% from 2013 to 2015 level.

    By Alex Chamberlin
  • uploads///imf
    Miscellaneous

    Outlook Projections: IMF Cuts Global Growth Forecasts

    The IMF cut its global economic growth forecasts, according to the latest IMF World Economic Output Update dated July 19. The cut in forecasts was expected.

    By David Meyer
  • uploads///Emerging Market Small Caps Have Higher Exposure to the Consumer Related Sectors
    Macroeconomic Analysis

    Emerging Market Small-Cap Stocks Focus on Local Sectors

    Emerging market small-cap stocks offer exposure to consumer sectors. EEMS has 18% exposure to consumer discretionary stocks.

    By Russ Koesterich, CFA
  • uploads///AdobeStock_
    Consumer

    Where Stanley Druckenmiller Is Bullish

    Last week, Duquesne Family Office, managed by Stanley Druckenmiller, filed its Q3 13F with the SEC. We’ll look at the fund’s top holdings, buys, and sells.

    By Rabindra Samanta
  • uploads///phg pm
    Company & Industry Overviews

    Exane BNP Paribas Upgrades Koninklijke Philips to ‘Outperform’

    Koninklijke Philips (PHG) has a market cap of $24.7 billion. It fell by 0.94% to close at $26.48 per share on May 11, 2016.

    By Gabriel Kane
  • Energy & Utilities

    Must-know: The assets of the Shell Midstream Partners

    Zydeco is a wholly owned subsidiary of SPLC, the general partner of Shell Midstream.

    By Alex Chamberlin
  • uploads///asian
    Macroeconomic Analysis

    Why Are Global Markets Range Bound?

    The contrasting movement among the global markets was primarily due to caution ahead of the Bank of England’s monetary policy release on July 14.

    By David Meyer
  • uploads///Chart
    Company & Industry Overviews

    Analysts’ Recommendations for GlaxoSmithKline in May

    GSK reported EPS of 24.60 British pence on revenue of 7.22 billion pounds, surpassing Wall Street analysts’ consensus estimates.

    By Mike Benson
  • Financials

    3 reasons why the US dollar should strengthen in 2014

    But while the currency has been range bound for the past two years, there are three reasons why I would expect a stronger dollar over the next year.

    By Russ Koesterich, CFA
  • uploads///fcau pm
    Company & Industry Overviews

    How Were Fiat Chrysler’s Sales in May?

    Fiat Chrysler Automobiles (FCAU) fell by 1.6% to close at $6.76 per share at the end of the third week of June 2016.

    By Gabriel Kane
  • uploads///Japan hsg
    Macroeconomic Analysis

    The Japanese Housing Sector Sent a Mixed Signal in December

    According to the Ministry of Land, Infrastructure and Transport, Japanese housing starts fell 1.3% in December YoY as compared to a rise of 1.7% in November.

    By Lara Sheldon
  • Financials

    Must-know: Risks of investing in the frontier

    You need to exercise caution while investing in frontier markets due to problems of liquidity and high concentration in the finance sector.

    By Russ Koesterich, CFA
  • uploads///   japan forex
    Financials

    US taper in 2014 will be a tailwind for the yen exchange rate

    While the US slows and eventually stops QE (quantitative easing), Japan will continue and likely increase QE In Part 1 of this series, I made the case that the BoJ (Bank of Japan) will likely step up its monetary easing, as current efforts haven’t led to the level of inflation it’s targeting. At the same […]

    By James Malthus, Macro Analyst
  • Financials

    Why emerging markets have underachieved since 2013

    I’ve been writing a lot lately about investing in emerging markets. It’s no wonder, then, that many investors are asking me for more details regarding my views of emerging market debt and equities.

    By Russ Koesterich, CFA
  • Financials

    Should you worry about the growing debt in emerging markets?

    Overall, emerging markets have debt levels relative to both gross domestic product and income that are still considerably lower than those of developed markets.

    By Russ Koesterich, CFA
  • uploads///MSCI Performance
    Financials

    Overview: 3 things to know about currency hedging

    Your total return depends on both equity and currency returns, which are sensitive to economic, political, and market events, and fluctuate over time.

    By BlackRock
  • Financials

    Must-know: Why international dividend funds give you better value

    While stocks offer better value than bonds, I would bring up exposure to international and global dividend funds rather than focus exclusively on U.S. dividend funds, which look more expensive.

    By Russ Koesterich, CFA
  • uploads///SP  Buyback Index Outperformed SP  Index
    Financials

    Icahn Identifies a Key Motivation behind the Buyback Spree in the US

    Carl Icahn is one of the first activist investors to voice his opinion against share buybacks. He believes that companies are increasingly putting money into buybacks instead of using them for much-needed capital improvements.

    By Surbhi Jain
  • uploads///Partnership Structure
    Energy & Utilities

    Why Shell Midstream Partners filed for an initial public offering

    During the 12 months ending March 31, 2014, Shell Midstream had pro-forma revenues of $99.8 million and net income of $89.6 million, according to its IPO filing.

    By Alex Chamberlin
  • uploads///central bankers as the community chest
    Financials

    Bill Gross: Unfortunately, We Aren’t Playing Monopoly

    In Monopoly, the $200 of credit creation never changes. In the real economy, credit creation isn’t guaranteed to occur at the same pace each year.

    By Surbhi Jain
  • uploads///bank lending
    Financials

    What If Low Interest Rates Don’t Result in Increased Lending?

    With most of the developed world at near zero or negative yields, the contribution of lowering interest rates to the velocity of money is diminishing.

    By Surbhi Jain
  • uploads///student debt and age
    Financials

    Millennials or Baby Boomers: Who’s Affected Most by Student Debt?

    The Baby Boomer generation has also been increasingly contributing to the student debt crisis.

    By Surbhi Jain
  • uploads///polls data nov
    Financials

    A Trump Presidency: What Are the Odds?

    With Hillary Clinton leading Donald Trump in the polls before Tuesday’s US presidential election, the projected results are still uncertain. However, a Trump victory may not be good news for those invested in emerging markets.

    By Surbhi Jain
  • Real Estate

    The “Great Deleveraging” that never happened: The US debt problem

    For several years, media headlines have been filled with references to a mythical “deleveraging,” or a reduction in the level of U.S. debt. In reality, U.S. non-financial debt has increased.

    By Russ Koesterich, CFA
  • uploads///Graph
    Company & Industry Overviews

    GlaxoSmithKline Could Witness Modest Rise in Revenues in 2017

    GlaxoSmithKline (GSK) is a leading player in the global respiratory market with a major focus on the asthma and chronic obstructive pulmonary disease (or COPD) segments.

    By Margaret Patrick
  • uploads///Kymriah Juliet
    Company & Industry Overviews

    Key Updates on Novartis’s Kymriah

    In December 2017, Novartis (NVS) presented updated results from the Juliet clinical trial, which demonstrated sustained responses of Kymriah (tisagenlecleucel) for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma (or DLBCL).

    By Daniel Collins
  • uploads///Chart  Alcon
    Earnings Report

    Reading the Estimates for Novartis’s Alcon in 4Q17

    For 4Q17, Alcon is expected to report growth in revenues, driven by the increased demand for contact lenses and surgical products.

    By Mike Benson
  • uploads///Zelboraf
    Company & Industry Overviews

    Zelboraf Could Boost Roche’s Sales Growth in 2018

    Roche’s (RHHBY) Zelboraf (vemurafenib) is indicated for the treatment of individuals with unresectable or metastatic melanoma with the BRAF V600 mutation.

    By Daniel Collins
  • uploads///Hemlibra
    Company & Industry Overviews

    How Is Roche’s Hemlibra Positioned for 2018?

    Roche’s (RHHBY) Hemlibra is used for the prevention and reduction of the frequency of bleeding episodes in individuals with hemophilia A with factor VIII inhibitors.

    By Daniel Collins
  • uploads///Polatuzumab
    Company & Industry Overviews

    What to Expect from Roche’s Investigational Drug Polatuzumab Vedotin

    In December 2017, Roche (RHHBY) presented the results of its randomized phase two GO29365 trial.

    By Daniel Collins
  • uploads///new generation insulin
    Company & Industry Overviews

    Novo Nordisk’s Xultophy, Ryzodeg, and Fiasp Could Boost Revenue Growth in 2018

    Novo Nordisk’s (NVO) Xultophy (insulin degludec and liraglutide combination) is used as an addition to diet and exercise for improvement of blood sugar levels in adults with type-2 diabetes mellitus whose blood sugar level could not be controlled adequately with basal insulin.

    By Daniel Collins
  • uploads///Chart  Ratings
    Company & Industry Overviews

    Analysts’ Recommendations for GlaxoSmithKline in November 2017

    Wall Street analysts estimate that GlaxoSmithKline’s (GSK) top line could fall 0.8% to ~7.5 billion pounds in 4Q17.

    By Mike Benson
  • uploads///Gazyva
    Company & Industry Overviews

    How Roche’s Oncology Drug Gazyva Is Positioned after 3Q17

    In 3Q17, Roche’s (RHHBY) Gazyva generated revenues of 69 million Swiss francs, which reflected ~34% growth on a year-over-year (or YoY) basis.

    By Daniel Collins
  • uploads///Novartis revenues
    Company & Industry Overviews

    How Did Novartis Perform in 1H17?

    In 1H17, Novartis (NVS) reported revenues of around $23.8 billion, a ~1% decline on a year-over-year (or YoY) basis.

    By Daniel Collins
  • uploads///Chart  EPS
    Company & Industry Overviews

    Changes in AstraZeneca’s Valuation after Its 2Q17 Earnings

    AstraZeneca’s (AZN) stock value has fallen ~11.9% over the last 12 months. Wall Street analysts estimate that the stock has the potential to return ~16.6% over the next 12 months.

    By Mike Benson
  • uploads///Chart  SWR
    Company & Industry Overviews

    How Did GlaxoSmithKline’s Segments Perform in 2Q17?

    GlaxoSmithKline’s Pharmaceuticals segment reported revenues of 4.36 billion pounds during 2Q17—12% growth compared to 2Q16.

    By Mike Benson
  • uploads///Chart  Rev EPS
    Company & Industry Overviews

    Behind Novartis’s Valuation after 2Q17

    Novartis missed the analysts’ estimate for 2Q17 revenues, reporting $12.24 billion and falling short of $12.27 billion, but surpassed the estimate for EPS.

    By Mike Benson
  • uploads///Graph
    Company & Industry Overviews

    How Analysts View Fresenius Medical Care and Its Peers in August 2017

    In 1H17, Fresenius Medical Care (FMS) reported revenues close to 9.0 billion euros, which represents 14% YoY growth. At the end of 2Q17, the company operated 3,690 dialysis clinics around the world.

    By Margaret Patrick
  • uploads///Chart  Rev
    Earnings Report

    GlaxoSmithKline’s 2Q17 Earnings Reveal Growth

    In its earnings release on July 26, GlaxoSmithKline (GSK) reported 12% growth to ~7.3 billion pounds in its 2Q17 revenues. GSK surpassed analysts’ estimates for revenues and earnings per share.

    By Mike Benson
  • uploads///bond yeilds
    Macroeconomic Analysis

    How Did Fixed Income Markets React to the First Round?

    Demand for fixed income securities will likely be subdued because of excess supply this week, which would mean additional support for bond yields.

    By Ricky Cove
  • uploads///Graph
    Company & Industry Overviews

    Entresto Could See Steep Rise in Total Prescriptions This Year

    Novartis’s (NVS) heart failure drug, Entresto, has been witnessing a steep rise in both new to brand prescriptions as well as total prescriptions in the US market.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    What to Expect from AstraZeneca’s Farxiga in 2017

    Despite intense competition, AstraZeneca (AZN) managed to report 11% year-over-year (or YoY) revenue growth for its diabetes franchise in 2016.

    By Margaret Patrick
  • uploads///Yield Curve Is Steepening
    Company & Industry Overviews

    Yield Curve Is Steepening: What Does It Indicate for the Market?

    In this series, we’ll compare yields across various developed markets (EFA) (VEA). We’ll also look at how a steepening yield curve affects the financial sector (XLF).

    By Sarah Sands
  • uploads///ifo
    Macroeconomic Analysis

    Why Did Ifo’s Release Show Gains in Construction and Retail?

    The overall Ifo business climate suffered a setback in July. Looking at the sector-based performance, the construction and retail sector saw a rise.

    By David Meyer
  • uploads///Inflation Interest Rates and FX
    Macroeconomic Analysis

    How Are Inflation, Interest Rates, and Foreign Exchange Related?

    A low rate of inflation doesn’t guarantee a favorable exchange rate. But a high inflation rate is likely to have a negative effect on a currency’s value.

    By Heather McArdle
  • uploads///fcau pm
    Company & Industry Overviews

    Moody’s Upgraded Fiat Chrysler’s Ratings

    Fiat Chrysler Automobiles (FCAU) has a market cap of $8.5 billion. It fell by 2.5% to close at $6.56 per share on July 19, 2016.

    By Gabriel Kane
  • uploads///german
    Macroeconomic Analysis

    Inflation Rises in United Kingdom: Should Go Higher on Weak Pound

    Inflation rate in the United Kingdom pushed higher to release at 0.5% on an annual basis in June. However, it was still below the central bank’s target of 2%.

    By David Meyer
  • uploads///european
    Macroeconomic Analysis

    Weak Data Puts Downward Pressure on European Indexes

    On July 6, major European indexes were trading lower for the second day. The fall in the indexes was led by the Italian FTSE MIB and the UK-based FTSE 100.

    By David Meyer
  • uploads///asia
    Macroeconomic Analysis

    Are Global Indexes Pointing to a Weak Start for US Markets?

    The fall in European markets was led by the German DAX and the French CAC 40—they fell by 1.3% and 1.4%, respectively.

    By David Meyer
  • uploads///asian
    Macroeconomic Analysis

    Does the FTSE 100 Reflect the United Kingdom’s Economic Sentiment?

    The FTSE 100 had a rollercoaster ride in the previous month. The index fell to a low of 5,788.74 on the day of the United Kingdom’s referendum results.

    By David Meyer
  • uploads///european
    Macroeconomic Analysis

    FTSE 100 Leads the Gains in Global Markets

    On June 29, the rise in European indexes was led by the United Kingdom’s index FTSE 100. It suffered the most since Brexit. The FTSE 100 rose by 3.6%.

    By David Meyer
  • uploads///fcau pm
    Company & Industry Overviews

    Fiat Chrysler Rose with Its Electric Vehicle Plan

    Fiat Chrysler Automobiles rose by more than 4.1% on June 20, 2016, after the news that it is planning to add full electric vehicles in its product line.

    By Gabriel Kane
  • uploads///SP  Buyback Index Outperformed SP  Index
    Macroeconomic Analysis

    Share Buybacks: Lower Valuation or Cheap Capital?

    By reducing the number of outstanding shares, companies increase the EPS. Through share buybacks, companies return more cash to shareholders.

    By Sarah Sands
  • uploads///mexico top exports
    Macroeconomic Analysis

    Consumerism Abroad to Drive Growth in Mexico

    Mexico is known for its industrial base. In 2015, vehicles constituted about 23.7% of Mexican exports, followed by electronic equipment at 21.3% of exports.

    By Surbhi Jain
  • uploads///Israels Economy Has Grown at a Steady Pace
    Macroeconomic Analysis

    Why Israel’s Economy Is Still Resilient

    Israel’s government debt as a proportion of gross national product has declined steadily this century.

    By Aberdeen Closed-End Funds
  • uploads///Euro
    Macroeconomic Analysis

    Eurozone Manufacturing Eased in January

    In-line with the flash estimate, the Eurozone’s manufacturing PMI (purchasing manufacturers’ index) stood at 52.3 in January 2016.

    By Lara Sheldon
  • uploads///sne pm
    Earnings Report

    Sony’s Revenue and Income Rose in 3Q15

    Sony (SNE) has a market cap of $29.8 billion. SNE rose by 17.7% to close at $23.88 per share as of January 29, 2016.

    By Gabriel Kane
  • uploads///sne pm
    Company & Industry Overviews

    Sony Fell on Falling Apple iPhone Production

    Sony (SNE) has a market capitalization of $30.2 billion. SNE fell by 7.2% to close at $23.63 per share on January 6, 2016.

    By Gabriel Kane
  • uploads///VIX
    Fund Managers

    Getting Caught in the Daily Indicators Hurts Your Bottom Line

    The president of Bank of America’s (BAC) wealth management business, Keith Banks, advises investors to have a long-term strategy at this point in the market.

    By Surbhi Jain
  • uploads///GDP
    Macroeconomic Analysis

    Bank of England Stays Put with Current Bank Rate

    The Bank of England Monetary Policy Committee (or MPC) voted by a majority of 8:1 to maintain a bank rate at 0.5% yesterday.

    By Lara Sheldon
  • uploads///Emerging Markets Provide Diversifying Benefits
    Macroeconomic Analysis

    American Investors Could Be Hurt by Home-Country Bias

    If you’re prone to home-country bias, consider diversifying. Adding emerging markets to your portfolio could improve your risk-adjusted returns.

    By Nelli Oster, PhD
  • uploads///Brazil Is One of the Youngest Major Economies
    Macroeconomic Analysis

    Why the Young Brazilian Population is Key to Brazil’s Success

    The young Brazilian population could revive the economy. A younger population is a key demographic indicator to watch out for.

    By Russ Koesterich, CFA
  • uploads///Annualized Changes in the GDP from the Previous Q
    Macroeconomic Analysis

    Central Bank Divergence Led to a Stronger US Dollar

    The disparity in GDP growth in the US and other major developed economies led to central bank divergence. The US is the only bright spot in developed markets.

    By Daniel Gamba
  • uploads///The declaration of the European QE led to the compression between peripheral and core bond yields
    Macroeconomic Analysis

    Quantitative Easings Led to Spread Compression in European Bonds

    The European Central Bank on Thursday, January 22, delivered­ basically what the market expected for QE (quantitative easing).

    By Jeffrey Rosenberg
  • uploads///Consumer confidence in Europe is still low
    Macroeconomic Analysis

    Low Consumer Confidence in Europe Has Affected Growth

    European citizens have gone through a lot of hardship in the last decade or so, which has resulted in low consumer confidence in Europe.

    By Russ Koesterich, CFA
  • uploads///Frontier markets add diversification benefits
    Macroeconomic Analysis

    Why Frontier Markets Are Good Diversifiers

    Frontier markets are good diversifiers. Frontier markets are still relatively insulated from the rest of the world.

    By Russ Koesterich, CFA
  • uploads///Stock Index and Currency in the Abenomics
    Macroeconomic Analysis

    What is the impact of Abenomics?

    In calling for a snap election, Shinzō Abe deferred the second hike in taxes from 8% to 10% by 18 months. This may not be a policy failure, but it certainly hints that the government will need to do more to help the economy find its legs.

    By David Ashworth
  • uploads///Moodys Rating Scale
    Macroeconomic Analysis

    What rating action did Moody’s announce for Japan?

    On December 1, 2014, Moody’s Investors Service, a business unit of Moody’s Corporation (MCO), downgraded Japan’s debt rating by one notch, from Aa3 to A1, with a stable outlook.

    By David Ashworth
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.